Genscript Biotech Overview
Pro stress-test →Genscript Biotech is an investment holding company that manufactures and sells life science research products and services globally through three segments: Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products. The company is positioning itself for increased market share and margin improvement in the life sciences sector through investments in automation, proprietary technology, and global expansion.
Strategic Profile
Pro stress-test →Innovative product launches and expanded regulatory compliance are supporting revenue diversification, pricing power, and long-term growth outside the China market. Recent earnings highlights showed significant revenue growth across all segments and strong performance of Legend Biotech's CAR-T product with a robust cash position.
Competitive Landscape
Pro stress-test →Genscript competes in synthetic biology and life sciences against companies like Twist Bioscience (TWST). The company differentiates through its integrated platform spanning gene synthesis, protein engineering, CAR-T development via Legend Biotech subsidiary, and industrial enzymes. Its market position strengthens through strategic partnerships including collaborations with Janssen and Novartis on CAR-T therapies.
Industry Context
Genscript Biotech operates in Synthetic Biology / Life Sciences Research and Therapeutics.
Key facts
Founded: 2002 · Headquarters: Nanjing, China